Open Label, Nonrandomized Clinical Trial of Safety and Tolerability of Enfuviritide (Fuzeon, HIV Fusion Inhibitor) in Patients With Advanced HIV1 Infection
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Roche
- 02 Jun 2006 New trial record.